Counterpoint Mutual Funds’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,334
Closed -$499K 414
2025
Q4
$499K Buy
+23,334
New +$478K 0.04% 184
2025
Q3
Sell
-52,586
Closed -$755K 419
2025
Q2
$755K Buy
52,586
+23,580
+81% +$323K 0.07% 76
2025
Q1
$420K Buy
29,006
+289
+1% +$4.11K 0.06% 141
2024
Q4
$377K Buy
+28,717
New +$396K 0.05% 166
2024
Q1
Sell
-10,140
Closed -$94.3K 201
2023
Q4
$94.3K Buy
10,140
+3,528
+53% +$36.5K 0.04% 99
2023
Q3
$84K Buy
+6,612
New +$90.7K 0.07% 268

Other funds holding MD

Counterpoint Mutual Funds's MD Position: Q1 2026 in Review

Counterpoint Mutual Funds sold out of Pediatrix Medical (MD) in Q1 2026, closing a stake of 23,334 shares — an estimated $499K sold.

Counterpoint Mutual Funds first reported a position in MD in Q3 2023 and held it in 6 quarters. The position peaked at $755K in Q2 2025. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Counterpoint Mutual Funds reported no remaining Pediatrix Medical position as of Q1 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 23,334 Pediatrix Medical shares in Q1 2026, an estimated $499K.
  • Counterpoint Mutual Funds first reported a position in Pediatrix Medical in Q3 2023 and held it in 6 quarters.
  • Counterpoint Mutual Funds's Pediatrix Medical position peaked at $755K in Q2 2025.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q1 2026, filed 27 Apr 2026.